Human regulatory T cells (Treg) and their response to cancer.
Theresa L Whiteside
Published in: Expert review of precision medicine and drug development (2019)
Context-related plasticity and heterogeneity of Treg in the TME are significant barriers to selective therapeutic depletion of those Treg subsets that are reprogramed by the tumor to suppress anti-tumor immunity.